These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 2175920)
1. ICI 198615 is an antagonist of leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious rat. Smith EF; Slivjak MJ Pharmacology; 1990; 41(2):57-66. PubMed ID: 2175920 [TBL] [Abstract][Full Text] [Related]
2. SK&F S-106203 inhibits leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious rat. Smith EF; Slivjak MJ; Egan JW; Eckardt RD; Newton JF Br J Pharmacol; 1990 Jun; 100(2):195-200. PubMed ID: 2165834 [TBL] [Abstract][Full Text] [Related]
3. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity. Smith EF; Slivjak MJ; Eckardt RD; Newton JF J Pharmacol Exp Ther; 1989 Jun; 249(3):805-11. PubMed ID: 2543811 [TBL] [Abstract][Full Text] [Related]
4. Evidence for high and low affinity leukotriene D4 receptors mediating vascular responses in the conscious rat. Smith EF; Slivjak MJ Eur J Pharmacol; 1989 Jan; 159(3):297-301. PubMed ID: 2537739 [TBL] [Abstract][Full Text] [Related]
5. Kinetic and pharmacologic analysis of [3H]leukotriene E4 binding to receptors on guinea pig lung membranes: evidence for selective binding to a subset of leukotriene D4 receptors. Aharony D; Catanese CA; Falcone RC J Pharmacol Exp Ther; 1989 Feb; 248(2):581-8. PubMed ID: 2537402 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of leukotrienes C4, D4, and E4 in the pulmonary and systemic vasculature of sheep. Ahmed T; Marchette B; Wasserman M; Wanner A; Yerger L Bull Eur Physiopathol Respir; 1986; 22(6):573-80. PubMed ID: 3030470 [TBL] [Abstract][Full Text] [Related]
7. In vivo pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist. Krell RD; Giles RE; Yee YK; Snyder DW J Pharmacol Exp Ther; 1987 Nov; 243(2):557-64. PubMed ID: 2824752 [TBL] [Abstract][Full Text] [Related]
8. Evidence for two leukotriene receptor types in the guinea-pig isolated ileum. Gardiner PJ; Abram TS; Cuthbert NJ Eur J Pharmacol; 1990 Jul; 182(2):291-9. PubMed ID: 2168834 [TBL] [Abstract][Full Text] [Related]
9. The pharmacological evaluation of LY 170680, a novel leukotriene D4 and E4 antagonist in the guinea-pig. Boot JR; Bond A; Gooderham R; O'Brien A; Parsons M; Thomas KH Br J Pharmacol; 1989 Sep; 98(1):259-67. PubMed ID: 2553189 [TBL] [Abstract][Full Text] [Related]
10. In vitro pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist. Snyder DW; Giles RE; Keith RA; Yee YK; Krell RD J Pharmacol Exp Ther; 1987 Nov; 243(2):548-56. PubMed ID: 2824751 [TBL] [Abstract][Full Text] [Related]
11. Tissue distribution and functional correlation of [3H]leukotriene C4 and [3H]leukotriene D4 binding sites in guinea-pig uterus and lung preparations. Cheng JB; Lang D; Bewtra A; Townley RG J Pharmacol Exp Ther; 1985 Jan; 232(1):80-7. PubMed ID: 2981321 [TBL] [Abstract][Full Text] [Related]
12. The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist. Krell RD; Aharony D; Buckner CK; Keith RA; Kusner EJ; Snyder DW; Bernstein PR; Matassa VG; Yee YK; Brown FJ Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):978-87. PubMed ID: 2158259 [TBL] [Abstract][Full Text] [Related]
13. Binding of radiolabeled high affinity antagonist to leukotriene D4 receptor in guinea pig lung membranes: interconversion of agonist-receptor binding affinity states. O'Sullivan BP; Mong S Mol Pharmacol; 1989 Jun; 35(6):795-802. PubMed ID: 2543913 [TBL] [Abstract][Full Text] [Related]
14. Cysteinyl leukotriene actions on the microcirculation of the normal and split hydronephrotic rat kidney. Gulbins E; Parekh N; Rauterberg EW; Schlottmann K; Steinhausen M Eur J Clin Invest; 1991 Apr; 21(2):184-96. PubMed ID: 1647953 [TBL] [Abstract][Full Text] [Related]
15. Biochemical and pharmacological characterization of ICI 198,615: a peptide leukotriene receptor antagonist. Krell RD; Kusner EJ; Aharony D; Giles RE Eur J Pharmacol; 1989 Jan; 159(1):73-81. PubMed ID: 2565238 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4. Buckner CK; Krell RD; Laravuso RB; Coursin DB; Bernstein PR; Will JA J Pharmacol Exp Ther; 1986 May; 237(2):558-62. PubMed ID: 3009792 [TBL] [Abstract][Full Text] [Related]
17. Preferential vasoconstriction to cysteinyl leukotrienes in the human saphenous vein compared with the internal mammary artery. Implications for graft performance. Allen SP; Chester AH; Dashwood MR; Tadjkarimi S; Piper PJ; Yacoub MH Circulation; 1994 Jul; 90(1):515-24. PubMed ID: 8026041 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of leukotriene C4, D4 and E4 in allergic inflammation in rats. Ohuchi K; Takahashi C; Watanabe M; Hirasawa N; Suzuki Y; Kudo M; Konishi T; Tsurufuji S J Clin Lab Immunol; 1988 Dec; 27(4):171-8. PubMed ID: 2855079 [TBL] [Abstract][Full Text] [Related]
19. Characterization of sulfidopeptide leukotriene responses in sheep tracheal smooth muscle in vitro. Tomioka K; Jackowski JT; Abraham WM Can J Physiol Pharmacol; 1991 Jun; 69(6):805-11. PubMed ID: 1655181 [TBL] [Abstract][Full Text] [Related]